Rankings
▼
Calendar
SCYX Q1 2018 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena
SCYX
SCYNEXIS, Inc.
$37M
Q1 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$64,000
+0.0% YoY
Gross Profit
$64,000
100.0% margin
Operating Income
-$7M
-11301.6% margin
Net Income
-$4M
-6253.1% margin
EPS (Diluted)
$-1.19
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$425,000
Balance Sheet
Total Assets
$65M
Total Liabilities
$29M
Stockholders' Equity
$37M
Cash & Equivalents
$27M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$64,000
$64,000
+0.0%
Gross Profit
$64,000
$64,000
+0.0%
Operating Income
-$7M
-$6M
-20.2%
Net Income
-$4M
-$5M
+17.8%
← FY 2018
All Quarters
Q2 2018 →